Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-108664
Filing Date
2024-10-15
Accepted
2024-10-15 17:19:19
Documents
4
Period of Report
2024-11-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2426177d1_pre14a.htm PRE 14A 415093
2 GRAPHIC tm2426177d1_pre14a-img01.jpg GRAPHIC 3903
3 GRAPHIC tm2426177d1_pre14a-img02.jpg GRAPHIC 128948
4 GRAPHIC tm2426177d1_pre14a-img03.jpg GRAPHIC 140047
  Complete submission text file 0001104659-24-108664.txt   792532
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39752 | Film No.: 241372698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)